advertisement

Topcon

Abstract #22266 Published in IGR 10-4

Intraocular pressure elevation after intravitreal triamcinolone acetonide injection in a Chinese population

Lau LI; Chen KC; Lee FL; Chen SJ; Ko YC; Liu CJ; Hsu WM
American Journal of Ophthalmology 2008; 146: 573-578


PURPOSE: To study the prevalence and risk factors of intraocular pressure (IOP) elevation and refractory IOP elevation after a single 4-mg intravitreal triamcinolone acetonide (IVTA) injection in a Chinese population. DESIGN: Retrospective, observational case series. METHODS: Retrospective chart review of all the patients who received an IVTA injection at one medical center from January 2003 through June 2005. A postoperative IOP increase of more than 6 mmHg was defined as an IOP elevation. Postoperative IOP elevation that could not be controlled by glaucoma medications was defined as refractory IOP elevation. RESULTS: Sixty-four (43.5%) of the 147 enrolled patients experienced IOP elevation. Males had a higher risk of IOP elevation, with an odds ratio (OR) of 3.17 (95% confidence interval [CI], 1.38 to 7.27; P = .006), after adjusting for age, glaucoma history, and diagnosis of retinal disease. Patients 55 years of age and younger had a larger magnitude of IOP elevation than those older than 55 years (11.2 ± 10.1 mmHg vs 7.3 ± 7.7 mmHg; P = .020). Ten patients (6.8%) had refractory IOP elevation, and those 55 years of age or younger had a higher risk of refractory IOP elevation compared with those older than 55 years, with an OR of 8.16 (95% CI, 1.67 to 39.81; P = .009), after adjusting for preoperative IOP and diagnosis of retinal disease. CONCLUSIONS: Elevated IOP after IVTA injection is common in this Chinese population. Male patients have a higher risk of IOP elevation. Younger patients should be monitored carefully after IVTA injection because they exhibit a greater magnitude of IOP elevation and have an increased chance of developing refractory IOP elevation.

Dr. L.I. Lau, Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan


Classification:



Issue 10-4

Change Issue


advertisement

Oculus